Growth Stocks

Showing 3178 articles
Business

Raymond James Financial Insiders Cash Out: A Signal for Investors?

A wave of insider selling at Raymond James Financial, including an $18 million sale by its Executive Chair, is drawing scrutiny from the market. While high insider ownership remains a positive, the lack of any recent buying activity raises questions about internal confidence in the stock's near-term valuation.

Business

Guardian Pharmacy Services: Is the Stock Fairly Valued After Recent Gains?

A deep dive into Guardian Pharmacy Services (NYSE:GRDN) using a discounted cash flow model suggests its current share price is hovering close to its estimated intrinsic value. While the analysis provides a quantitative benchmark, investors are cautioned that valuation is just one piece of the puzzle in a complex and regulated healthcare sector.